Dr. Sven Rihm is a German and European patent lawyer with more than 15 years experience in the field of intellectual property. Sven advises clients in all aspects of patent prosecution as well as invalidation and litigation of intellectual property matters. He represents clients in all technical aspects of organic, inorganic, and polymer chemistry as well as in technologies related to life science, biotechnology, and pharmaceuticals.
Sven represents clients such as BioMarin Pharmaceuticals, Celgene Corporation, Idenix Pharmaceuticals, PTC Therapeutics, and Signal Pharmaceuticals. Among other matters, he was involved in defending European patents of Idenix Pharmaceuticals covering nucleoside analogues for treating HCV infections in opposition proceedings.
Prior to joining Jones Day, Sven practiced at one of Germany's largest law firms and at a small German IP boutique. He has handled numerous oppositions, freedom-to-operate and due diligence analyses, and infringement actions. He has represented clients in oral proceedings before the Opposition Division and the Boards of Appeal at the European Patent Office.
Sven is a member of the German Patent Lawyer's Association (PAK), the Institute of Professional Representatives before the European Patent Office (epi), the International Federation of Industrial Property Attorneys (FICPI), and the Association of Intellectual Property Experts (VPP).
- European Qualifying Examination (2008); German Patent Bar Exam (2005); University of Heidelberg (Dr. rer. nat. 2002; Diploma in Chemistry 1999)
- European Patent Office (EPO), German Patent and Trademark Office (GPTO), German Federal Patent Court (BPatG), German Federal Supreme Court (BGH) in nullity appeal proceedings, German Federal Office for Plant Varieties (BSA), International Bureau of WIPO (IB), and Office for Harmonization in the Internal Market (OHIM, European Community Trademarks and Designs)
- German and English